| Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease M Masarone, V Rosato, M Dallio, AG Gravina, A Aglitti, C Loguercio, ... Oxidative medicine and cellular longevity 2018 (1), 9547613, 2018 | 666 | 2018 |
| NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome V Rosato, M Masarone, M Dallio, A Federico, A Aglitti, M Persico International journal of environmental research and public health 16 (18), 3415, 2019 | 143 | 2019 |
| Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage M Masarone, V Rosato, A Aglitti, T Bucci, R Caruso, T Salvatore, ... PLoS one 12 (6), e0178473, 2017 | 112 | 2017 |
| The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights A Federico, V Rosato, M Masarone, P Torre, M Dallio, M Romeo, ... Nutrients 13 (4), 1314, 2021 | 70 | 2021 |
| Epidemiology and natural history of alcoholic liver disease M Masarone, V Rosato, M Dallio, L Abenavoli, A Federico, C Loguercio, ... Reviews on recent clinical trials 11 (3), 167-174, 2016 | 70 | 2016 |
| Non alcoholic fatty liver disease and eNOS dysfunction in humans M Persico, M Masarone, A Damato, M Ambrosio, A Federico, V Rosato, ... BMC gastroenterology 17, 1-9, 2017 | 67 | 2017 |
| Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis L Rinaldi, F Nascimbeni, M Giordano, C Masetti, B Guerrera, A Amelia, ... World Journal of Gastroenterology 23 (8), 1458, 2017 | 60 | 2017 |
| Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis M Persico, V Rosato, A Aglitti, D Precone, M Corrado, AD Luna, F Morisco, ... Antiviral Therapy 23 (2), 129-138, 2018 | 50 | 2018 |
| Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets AG Gravina, M Dallio, M Masarone, V Rosato, A Aglitti, M Persico, ... Oxidative medicine and cellular longevity 2018 (1), 2568569, 2018 | 50 | 2018 |
| Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma R Nevola, G Tortorella, V Rosato, L Rinaldi, S Imbriani, P Perillo, ... Biology 12 (7), 984, 2023 | 47 | 2023 |
| Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study M Persico, A Aglitti, M Milella, C Coppola, V Messina, E Claar, I Gentile, ... Liver International 39 (10), 1852-1859, 2019 | 44 | 2019 |
| Alcoholic hepatitis: pathogenesis, diagnosis and treatment L Abenavoli, M Masarone, A Federico, V Rosato, M Dallio, C Loguercio, ... Reviews on recent clinical trials 11 (3), 159-166, 2016 | 42 | 2016 |
| Pharmacotherapy of alcoholic liver disease in clinical practice V Rosato, L Abenavoli, A Federico, M Masarone, M Persico International Journal of Clinical Practice 70 (2), 119-131, 2016 | 40 | 2016 |
| Hepatocellular carcinoma in HCV cirrhosis after viral clearance with direct acting antiviral therapy: preliminary evidence and possible meanings L Rinaldi, R Di Francia, N Coppola, B Guerrera, M Imparato, C Monari, ... Wcrj 3 (3), e748, 2016 | 38 | 2016 |
| Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma M Masarone, A De Renzo, V La Mura, FC Sasso, M Romano, ... BMC gastroenterology 14, 1-10, 2014 | 37 | 2014 |
| Pressure support ventilation vs continuous positive airway pressure for treating of acute cardiogenic pulmonary edema: a pilot study A Pagano, FG Numis, V Rosato, T Russo, G Porta, G Bosso, C Serra, ... Respiratory Physiology & Neurobiology 255, 7-10, 2018 | 19 | 2018 |
| Elimination of hepatitis C in Southern Italy: A model of HCV screening and linkage to care among hospitalized patients at different hospital divisions V Rosato, LA Kondili, R Nevola, P Perillo, D Mastrocinque, A Aghemo, ... Viruses 14 (5), 1096, 2022 | 18 | 2022 |
| Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis L Rinaldi, A Ascione, V Messina, V Rosato, G Valente, V Sangiovanni, ... Infection 46, 231-238, 2018 | 18 | 2018 |
| HBV infection and host interactions: the role in viral persistence and oncogenesis R Nevola, D Beccia, V Rosato, R Ruocco, D Mastrocinque, A Villani, ... International journal of molecular sciences 24 (8), 7651, 2023 | 17 | 2023 |
| Rapid virological response represents the highest prediction factor of response to antiviral treatment in HCV-related chronic hepatitis: a multicenter retrospective study A Federico, M Masarone, M Romano, M Dallio, V Rosato, M Persico Hepatitis monthly 15 (6), e18640, 2015 | 15 | 2015 |